PET/CT F-PSMA（[F]DCFPyL）中气管支气管树摄取：一种生理性分布变异 - Suppr | 超能文献

Tracheo-bronchial tree uptake in PET/CT F-PSMA ([F]DCFPyL) a variant of physiological distribution.

作者信息

Spinelli V, Peiró V, Llorente E

机构信息

Departamento de Diagnóstico por Imagen, Hospital Universitario de Fuenlabrada, Madrid, Spain.

Departamento de Diagnóstico por Imagen, Hospital Universitario de Fuenlabrada, Madrid, Spain.

出版信息

Rev Esp Med Nucl Imagen Mol (Engl Ed). 2023 May-Jun;42(3):195. doi: 10.1016/j.remnie.2022.09.008. Epub 2022 Sep 22.

DOI:10.1016/j.remnie.2022.09.008

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Tracheo-bronchial tree uptake in PET/CT F-PSMA ([F]DCFPyL) a variant of physiological distribution.PET/CT F-PSMA（[F]DCFPyL）中气管支气管树摄取：一种生理性分布变异

Rev Esp Med Nucl Imagen Mol (Engl Ed). 2023 May-Jun;42(3):195. doi: 10.1016/j.remnie.2022.09.008. Epub 2022 Sep 22.

2

Improved identification of patients with oligometastatic clear cell renal cell carcinoma with PSMA-targeted F-DCFPyL PET/CT.PSMA 靶向 F-DCFPyL PET/CT 提高寡转移型透明细胞肾细胞癌患者的识别能力。

Ann Nucl Med. 2019 Aug;33(8):617-623. doi: 10.1007/s12149-019-01371-8. Epub 2019 May 30.

3

The prostate-specific membrane antigen (PSMA)-targeted radiotracer F-DCFPyL detects tumor neovasculature in metastatic, advanced, radioiodine-refractory, differentiated thyroid cancer.前列腺特异性膜抗原（PSMA）靶向放射性示踪剂 F-DCFPyL 可检测转移性、晚期、放射性碘难治性、分化型甲状腺癌中的肿瘤新生血管。

Med Oncol. 2020 Oct 9;37(11):98. doi: 10.1007/s12032-020-01427-0.

4

Prospective Comparison of PET Imaging with PSMA-Targeted F-DCFPyL Versus NaF for Bone Lesion Detection in Patients with Metastatic Prostate Cancer.PSMA 靶向 F-DCFPyL PET 显像与 NaF 用于检测转移性前列腺癌骨转移病灶的前瞻性比较。

J Nucl Med. 2020 Feb;61(2):183-188. doi: 10.2967/jnumed.119.227793. Epub 2019 Aug 26.

5

Detection of prostate cancer with F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial.F-DCFPyL PET/CT 检测与根治性前列腺切除术标本最终组织病理学比较：PSMA 靶向活检是否可行？DeTeCT 试验。

World J Urol. 2021 Jul;39(7):2439-2446. doi: 10.1007/s00345-020-03490-8. Epub 2020 Oct 20.

6

Healthy Tissue Uptake of Ga-Prostate-Specific Membrane Antigen, F-DCFPyL, F-Fluoromethylcholine, and F-Dihydrotestosterone.健康组织对 Ga-前列腺特异性膜抗原、F-DCFPyL、F-氟甲基胆碱和 F-二氢睾酮的摄取。

J Nucl Med. 2019 Aug;60(8):1111-1117. doi: 10.2967/jnumed.118.222505. Epub 2019 Jan 10.

7

Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted F-DCFPyL in peripheral ganglia.外周神经节中前列腺特异性膜抗原（PSMA）靶向的F-DCFPyL摄取模式。

Ann Nucl Med. 2017 Nov;31(9):696-702. doi: 10.1007/s12149-017-1201-4. Epub 2017 Aug 22.

8

Semiquantitative Parameters in PSMA-Targeted PET Imaging with [F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake.[F]DCFPyL 标记的 PSMA 靶向 PET 成像中的半定量参数：肿瘤负荷对正常器官摄取的影响。

Mol Imaging Biol. 2020 Feb;22(1):190-197. doi: 10.1007/s11307-019-01375-w.

9

F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local Therapy.F-DCFPyL PET/CT 成像在原发性局部治疗后生化复发前列腺癌患者中的应用。

J Nucl Med. 2020 Jun;61(6):881-889. doi: 10.2967/jnumed.119.234799. Epub 2019 Nov 1.

10

Peripheral ganglia in healthy rats as target structures for the evaluation of PSMA imaging agents.健康大鼠的周围神经节作为 PSMA 成像剂评估的靶结构。

BMC Cancer. 2019 Jun 26;19(1):633. doi: 10.1186/s12885-019-5841-8.

引用本文的文献

1

F-DCFPyL PSMA PET/CT Tracheobronchial Uptake in Patients with Prostate Cancer: Incidence and Etiology.F-DCFPyL PSMA PET/CT 示踪剂在前列腺癌患者气管支气管摄取：发生率和病因。

J Nucl Med. 2024 Sep 3;65(9):1383-1386. doi: 10.2967/jnumed.124.267772.